Initial experience of pacemaker and implantable cardioverter defibrillator lead extraction with the new GlideLight 80 Hz laser sheaths

被引:15
|
作者
Hakmi, Samer [1 ]
Pecha, Simon [1 ]
Sill, Bjoern [1 ]
Reiter, Beate [1 ]
Willems, Stephan [2 ]
Aydin, Muhammet Ali [2 ]
Yildirim, Yalin [1 ]
Reichenspurner, Hermann [1 ]
Treede, Hendrik [1 ]
机构
[1] Univ Heart Ctr Hamburg, Dept Cardiovasc Surg, D-20246 Hamburg, Germany
[2] Univ Heart Ctr Hamburg, Dept Cardiol, D-20246 Hamburg, Germany
关键词
Laser lead extraction; Pacemaker; Implantable cardioverter defibrillators; UNITED-STATES; OUTCOMES; TRENDS;
D O I
10.1093/icvts/ivt428
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Laser lead extraction is a challenging procedure, especially in patients with old or multiple pacemaker (PM) or implantable cardioverter defibrillator (ICD) leads. The mechanical force is a leading cause of complications during the extraction procedure. Use of new laser sheaths, which deliver a rate of 80 pulses per second, may probably reduce intraoperative adverse events by reduction of extraction force. METHODS: Between January 2012 and April 2013, 76 PM and ICD leads were treated in 38 patients using GlideLight 80 Hz laser sheaths. Indications for lead removals were pocket infection (42.1%), septicaemia or endocarditis (23.7%), lead dysfunction (31.6%) and upgrade from PM to ICD (2.6%). Data on procedural success rates, intra-and postoperative outcomes, as well as 30-day mortality were collected into a database and analysed retrospectively. RESULTS: The mean patient age was 62.0 +/- 17.7 years (range 18-83), and 73.7% were male. The mean time from initial lead implantation was 96.0 +/- 58.3 months (range 24-288). Thirty-seven (48.7%) PM and 39 (51.3%) ICD leads had to be extracted. The mean procedural time was 68.3 +/- 27.3 min (range 35-115). Seventy-two of 76 leads (94.8%) were completely removed, partial removal was achieved in 2 (2.6%) leads and a failure of extraction occurred in 2 (2.6%) leads. The overall complication rate was 5.2%, including one major (superior vena cava perforation) (2.6%) and one minor (pocket haematoma) (2.6%) complication. No death occurred during the 30-day follow-up. CONCLUSIONS: The GlideLight 80 Hz laser sheath allows safe and effective removal of chronically implanted PM and ICD leads, combining high procedural success with low complication rates.
引用
收藏
页码:56 / 60
页数:5
相关论文
共 50 条
  • [41] Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults with congenital heart disease
    Cooper, JM
    Stephenson, EA
    Berul, CI
    Walsh, EP
    Epstein, LM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 137A - 137A
  • [42] Conductor externalization of the RIATA implantable cardioverter defibrillator lead: a challenging lead extraction requiring laser-powered sheath
    Migliore, Federico
    Bertaglia, Emanuele
    Bontempi, Luca
    Verlato, Roberto
    Leoni, Loira
    Iliceto, Sabino
    Curnis, Antonio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (10) : 755 - 756
  • [43] Pacemaker and Internal Cardioverter Defibrillator Lead Extraction: A Safe and Effective Surgical Approach
    Kratz, John M.
    Toole, John M.
    ANNALS OF THORACIC SURGERY, 2010, 90 (05): : 1411 - 1417
  • [44] Safety and effectiveness of transvenous extraction of pacemaker and implantable cardioverter-defibrillator leads in patients under or over 80 years of age
    Kempa, Maciej
    Budrejko, Szymon
    Piepiorka, Marta
    Rogowski, Jan
    Raczak, Grzegorz
    Kozlowski, Dariusz
    KARDIOLOGIA POLSKA, 2013, 71 (02) : 130 - 135
  • [45] A novel indication for transvenous lead extraction: Upgrading implantable cardioverter defibrillator systems
    Korley, VJ
    Hallet, N
    Daoust, M
    Epstein, LM
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2000, 4 (03) : 523 - 528
  • [46] IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANTED BY NONTHORACOTOMY APPROACH - INITIAL CLINICAL-EXPERIENCE WITH THE REDESIGNED TRANSVENOUS LEAD SYSTEM
    MOORE, SL
    MALONEY, JD
    EDEL, TB
    MCGUINN, WP
    GOHN, D
    MORANT, VA
    TROHMAN, R
    SIMMONS, TW
    WILKOFF, BL
    CASTLE, LW
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (11): : 1865 - 1869
  • [47] A novel indication for transvenous lead extraction: Upgrading implantable cardioverter defibrillator systems
    Korley V.J.
    Hallet N.
    Daoust M.
    Epstein L.M.
    Journal of Interventional Cardiac Electrophysiology, 2000, 4 (3) : 523 - 528
  • [48] Initial clinical experience with the first dual-chamber implantable cardioverter defibrillator
    Lavergne, TT
    Ritter, PP
    Nitzsche, RR
    Saoudi, NN
    Kacet, SS
    Ollitrault, JJ
    Daubert, JCJC
    Lacroix, DD
    Poly, HH
    CIRCULATION, 1996, 94 (08) : 3287 - 3287
  • [49] Initial clinical experience with a dual chamber rate responsive implantable cardioverter defibrillator
    Luceri, RM
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2000, 23 (11): : 1986 - 1988
  • [50] Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy
    Kühlkamp, V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 790 - 797